The Global Sickle Cell Market is estimated to grow from USD 2450 million in 2021 to USD 4860 million by 2026 at a healthy CAGR of 14.68% during the forecast period. Increasing prevalence of sickle cell traits among patients, increasing clinical trials using various therapies are the factors driving the growth of sickle cell market.